Mark E. Lobatto
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 5%
Papers in
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 14
- Immunology 11
- Atherosclerosis and Cardiovascular Diseases 11
- Co-authors
- Willem J. M. Mulder (19 shared papers)Zahi Adel Fayad (19 shared papers)Valentı́n Fuster (3 shared papers)Claudia Calcagno (13 shared papers)Edward A A Fisher (3 shared papers)Erik S. G. Stroes (8 shared papers)Ronald E. Gordon (3 shared papers)Gerrit Storm (7 shared papers)
- Journals
- Journal of the American College of Cardiology (3 papers)Bioconjugate Chemistry (2 papers)Annals of Surgery (2 papers)JACC. Cardiovascular imaging (2 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Mark E. Lobatto
27 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 88
- Biomaterials 1.2k
- Drug Discovery 13
- Immunology 684
- Radiology, Nuclear Medicine and Imaging 440
- Biomedical Engineering 472
Countries citing papers authored by Mark E. Lobatto
This map shows the geographic impact of Mark E. Lobatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lobatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lobatto more than expected).
Fields of papers citing papers by Mark E. Lobatto
This network shows the impact of papers produced by Mark E. Lobatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lobatto. The network helps show where Mark E. Lobatto may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Lobatto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 395 | |
| 2 | 2011 | 362 | |
| 3 | 2008 | 287 | |
| 4 | 2015 | 201 | |
| 5 | 2014 | 170 | |
| 6 | 2010 | 145 | |
| 7 | 2015 | 144 | |
| 8 | 2015 | 143 | |
| 9 | 2015 | 111 | |
| 10 | 2014 | 90 | |
| 11 | 2016 | 89 | |
| 12 | 2018 | 82 | |
| 13 | 2011 | 80 | |
| 14 | 2019 | 64 | |
| 15 | 2011 | 45 | |
| 16 | 2008 | 44 | |
| 17 | 2018 | 43 | |
| 18 | 2015 | 41 | |
| 19 | 2020 | 37 | |
| 20 | 2015 | 35 |
About Mark E. Lobatto
Mark E. Lobatto is a scholar working on Biomaterials, Immunology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Biomedical Engineering, having authored 28 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Atherosclerosis and Cardiovascular Diseases (11 papers), Cardiac Imaging and Diagnostics (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Nanoplatforms for cancer theranostics (3 papers), Cholesterol and Lipid Metabolism (2 papers), COVID-19 Clinical Research Studies (2 papers) and Advanced MRI Techniques and Applications (2 papers). The work is most often cited by research in Biomaterials (1.2k citations), Drug Discovery (13 citations), Immunology (684 citations), Radiology, Nuclear Medicine and Imaging (440 citations) and Biomedical Engineering (472 citations). Mark E. Lobatto has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Willem J. M. Mulder, Zahi Adel Fayad, Valentı́n Fuster, Claudia Calcagno, Edward A A Fisher, Erik S. G. Stroes, Ronald E. Gordon, Gerrit Storm, David P. Cormode and François Fay. Their work appears in journals such as Journal of the American College of Cardiology, Bioconjugate Chemistry, Annals of Surgery, JACC. Cardiovascular imaging and Nanomedicine Nanotechnology Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.